Back to top

NKTR Initiates Coverage On Canaccord Genuity -- Rating Set to Buy

NKTR Initiates Coverage On Canaccord Genuity -- Rating Set to Buy

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nektar Therapeutics (NKTR)